Rick E Winningham
2014 - Innoviva
In 2014, Rick E Winningham earned a total compensation of $6.5M as Former Chief Executive Officer at Innoviva, a 275% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $383,921 |
|---|---|
| Salary | $511,898 |
| Stock Awards | $5,650,122 |
| Other | $500 |
| Total | $6,546,441 |
Winningham received $5.7M in stock awards, accounting for 86% of the total pay in 2014.
Winningham also received $383.9K in non-equity incentive plan, $511.9K in salary and $500 in other compensation.
Rankings
In 2014, Rick E Winningham's compensation ranked 1,049th out of 13,032 executives tracked by ExecPay. In other words, Winningham earned more than 92.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,049 out of 13,032 | 92nd |
Division Manufacturing | 381 out of 4,966 | 92nd |
Major group Chemicals And Allied Products | 125 out of 1,686 | 93rd |
Industry group Drugs | 99 out of 1,365 | 93rd |
Industry Pharmaceutical Preparations | 88 out of 1,043 | 92nd |
Source: SEC filing on March 24, 2015.
Winningham's colleagues
We found six more compensation records of executives who worked with Rick E Winningham at Innoviva in 2014.
2014
Michael Aguiar
Innoviva
Chief Executive Officer
2014
Mathai Mammen
Innoviva
Former Senior Vice President, Research & Development
2014
Leonard Blum
Innoviva
Former Senior Vice President and Chief Commercial Officer
2014
Eric d'Esparbes
Innoviva
Chief Financial Officer
2014
George Abercrombie
Innoviva
Senior Vice President and Chief Commercial Officer
2014
Theodore Witek
Innoviva
Chief Scientific Officer
News
Theravance Biopharma CEO Rick Winningham's 2023 pay falls 31% to $4.3M
April 5, 2024
Theravance Biopharma CEO Rick Winningham's 2020 pay rises 11% to $6.6M
March 22, 2021
Theravance Biopharma CEO Rick Winningham's 2019 pay jumps 135% to $5.9M
March 24, 2020
Theravance Biopharma Former Senior Vice President, Corporate Development and Strategy Shehnaaz Suliman's 2018 pay falls 35% to $2.7M
March 20, 2019